Speculations Spark-off: Is A Deal Cooking Between Pfizer And India's Dr. Reddy's Labs?
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Repeated denials of an imminent sell-off by India's Dr. Reddy's Labs failed to subdue a fresh round of speculations that linked Pfizer, a company said to be interested in buying out the domestic formulations business from the Hyderabad-headquartered company. Pfizer did not wish to comment and Dr. Reddy's strongly denied any plans to sell
You may also be interested in...
Dr. Reddy's CEO Dodges GSK Equity Deal Rumors - PharmAsia Summit
SAN FRANCISCO - Emotions should not come in the way of promoters wanting to sell their businesses, said Dr. Reddy's Labs Vice Chairman G.V. Prasad, while eluding questions pointed at a widely speculated equity deal between his company and GlaxoSmithKline
GSK In Pact With India’s Dr Reddy’s; Digs Deeper Into Emerging Generic Drugs Market
MUMBAI - Expanding its reach further into emerging markets for generic drugs, GlaxoSmithKline said it has reached an agreement with Dr. Reddy's Labs to develop and market select products across an extensive number of countries, except India
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).